science
plus
.abes.fr
|
explorer
À propos de :
Kim K.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Kim K.
Kim S. J.
Kim H.-J.
Kim W. S.
Kim B. S.
personal mailbox
wskimsmc@skku.edu
familyName
Kim
Given name
K.
W. S.
S. J.
H.-J.
S.-K.
B. S.
is
relates
of
http://hub.abes.fr/bmj/periodical/ard/2013/volume_72/issue_suppl3/B350DCD612EC6397E053120B220A4475/authorship/1
http://hub.abes.fr/oup/periodical/annonc/2009/volume_20/issue_2/101093annoncmdn726/authorship/1
http://hub.abes.fr/bmj/periodical/ard/2013/volume_72/issue_suppl3/B350A93595850842E053120B220A5074/authorship/1
http://hub.abes.fr/oup/periodical/annonc/2009/volume_20/issue_2/101093annoncmdn726/authorship/2
http://hub.abes.fr/oup/periodical/annonc/2009/volume_20/issue_2/101093annoncmdn726/authorship/3
http://hub.abes.fr/oup/periodical/annonc/2009/volume_20/issue_2/101093annoncmdn726/authorship/7
http://hub.abes.fr/bmj/periodical/ard/2013/volume_72/issue_suppl3/B350A93596330842E053120B220A5074/authorship/21
http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_5/101093annoncmdp412/authorship/1
http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_5/101093annoncmdp412/authorship/11
http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_5/101093annoncmdp412/authorship/12
http://hub.abes.fr/oup/periodical/annonc/2010/volume_21/issue_5/101093annoncmdp412/authorship/9
http://hub.abes.fr/oup/periodical/annonc/2008/volume_19/issue_12/101093annoncmdn431/authorship/8
http://hub.abes.fr/oup/periodical/annonc/2008/volume_19/issue_12/101093annoncmdn431/authorship/10
is
Author
of
Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
